BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 16341716)

  • 1. QSAR for anti-malarial activity of 2-aziridinyl and 2,3-bis(aziridinyl)-1,4-naphthoquinonyl sulfonate and acylate derivatives.
    Zahouily M; Lazar M; Elmakssoudi A; Rakik J; Elaychi S; Rayadh A
    J Mol Model; 2006 Mar; 12(4):398-405. PubMed ID: 16341716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and antimalarial activity of 2-aziridinyl- and 2,3-bis(aziridinyl)-1,4-naphthoquinonyl sulfonate and acylate derivatives.
    Lin TS; Zhu LY; Xu SP; Divo AA; Sartorelli AC
    J Med Chem; 1991 May; 34(5):1634-9. PubMed ID: 2033589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular modeling and 3D-QSAR studies in 2-aziridinyl-and 2,3-bis(aziridinyl)-1,4-naphthoquinonyl sulfonate and acylate derivatives as potential antimalarial agents.
    Pandey SK; Naware NB; Trivedi P; Saxena AK
    SAR QSAR Environ Res; 2001; 12(6):547-64. PubMed ID: 11813805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MIA-QSAR coupled to different regression methods for the modeling of antimalarial activities of 2-aziridinyl and 2,3-bis-(aziridinyl)-1,4-naphtoquinonyl sulfate and acylate derivatives.
    Goodarzi M; Freitas MP
    Med Chem; 2011 Nov; 7(6):645-54. PubMed ID: 22313304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QSAR modeling for the antimalarial activity of 1,4-naphthoquinonyl derivatives as potential antimalarial agents.
    Luan F; Xu X; Cordeiro MN; Liu H; Zhang X
    Curr Comput Aided Drug Des; 2013 Mar; 9(1):95-107. PubMed ID: 23157413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative structure-activity relationship in aziridinyl-1,4-naphthoquinone antimalarials: study of theoretical correlations by the PM3 method.
    dos Santos EV; Carneiro JW; Ferreira VF
    Bioorg Med Chem; 2004 Jan; 12(1):87-93. PubMed ID: 14697773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative structure-activity relationship to predict the anti-malarial activity in a set of new imidazolopiperazines based on artificial neural networks.
    Yousefinejad S; Mahboubifar M; Eskandari R
    Malar J; 2019 Sep; 18(1):310. PubMed ID: 31521174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QSAR for anti-HIV activity of HEPT derivatives.
    Bazoui H; Zahouily M; Boulajaaj S; Sebti S; Zakarya D
    SAR QSAR Environ Res; 2002 Oct; 13(6):567-77. PubMed ID: 12479372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel 1,4-naphthoquinone-based sulfonamides: Synthesis, QSAR, anticancer and antimalarial studies.
    Pingaew R; Prachayasittikul V; Worachartcheewan A; Nantasenamat C; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
    Eur J Med Chem; 2015 Oct; 103():446-59. PubMed ID: 26397393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-cytotoxicity relationships for a series of HEPT derivatives.
    Bazoui H; Zahouily M; Sebti S; Boulajaaj S; Zakarya D
    J Mol Model; 2002 Jan; 8(1):1-7. PubMed ID: 12111397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative structure-diastereoselectivity relationships for arylsulfoxide derivatives in radical chemistry.
    Zahouily M; Rayadh A; Aadil M; Zakarya D
    J Mol Model; 2003 Aug; 9(4):242-7. PubMed ID: 12768446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. QSAR Study of Artemisinin Analogues as Antimalarial Drugs by Neural Network and Replacement Method.
    Abbasitabar F; Zare-Shahabadi V
    Drug Res (Stuttg); 2017 Aug; 67(8):476-484. PubMed ID: 28561237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. QSAR study on the antimalarial activity of Plasmodium falciparum dihydroorotate dehydrogenase (PfDHODH) inhibitors.
    Hou X; Chen X; Zhang M; Yan A
    SAR QSAR Environ Res; 2016; 27(2):101-24. PubMed ID: 26911561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
    Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
    J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationship study of antimalarial indolo [2,1-b]quinazoline-6,12-diones (tryptanthrins). Three dimensional pharmacophore modeling and identification of new antimalarial candidates.
    Bhattacharjee AK; Hartell MG; Nichols DA; Hicks RP; Stanton B; van Hamont JE; Milhous WK
    Eur J Med Chem; 2004 Jan; 39(1):59-67. PubMed ID: 14987834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo antimalarial activity of novel 2-hydroxy-3-anilino-1,4-naphthoquinones obtained by epoxide ring-opening reaction.
    de Rezende LC; Fumagalli F; Bortolin MS; de Oliveira MG; de Paula MH; de Andrade-Neto VF; Emery Fda S
    Bioorg Med Chem Lett; 2013 Aug; 23(16):4583-6. PubMed ID: 23850202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development predictive QSAR models for artemisinin analogues by various feature selection methods: a comparative study.
    Abbasitabar F; Zare-Shahabadi V
    SAR QSAR Environ Res; 2012 Jan; 23(1-2):1-15. PubMed ID: 22040327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Multiple Linear Regressions and Neural Networks based QSAR models for the design of new antitubercular compounds.
    Ventura C; Latino DA; Martins F
    Eur J Med Chem; 2013; 70():831-45. PubMed ID: 24246731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2D-quantitative structure-activity relationships model using PLS method for anti-malarial activities of anti-haemozoin compounds.
    Nguyen PTV; Van Dat T; Mizukami S; Nguyen DLH; Mosaddeque F; Kim SN; Nguyen DHB; Đinh OT; Vo TL; Nguyen GLT; Quoc Duong C; Mizuta S; Tam DNH; Truong MP; Huy NT; Hirayama K
    Malar J; 2021 Jun; 20(1):264. PubMed ID: 34116665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions between potential anti-tumour 2,5-bis(1-aziridinyl)-1,4-benzoquinone derivatives and glutathione: reductive activation, conjugation and DNA damage.
    Lusthof KJ; de Mol NJ; Janssen LH; Prins B; Verboom W; Reinhoudt DN
    Anticancer Drug Des; 1990 Aug; 5(3):283-90. PubMed ID: 2205226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.